Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

New technologies such as open-RAN and equipment standardization will make it difficult for Nokia to differentiate itself. Open-RAN specifically threatens Nokia’s leadership, as the technology enables ...

Switchgrass has gripped Midwestern soils for millions of years, but soon, the earthbound prairie grass could fly. New studies ...

Most companies think they are doing win-loss analysis when they are actually relying on internal opinions, anecdotes or ...

The company has higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $36.79 Billion, which is 52.56x above the industry average, indicating stronger profitability and ...

Strengthen your local SEO by understanding your competitor's strategies, refining your approach, and targeting key ...